While U.S. cervical cancer rates have fallen by 70% since the 1950s thanks to the Pap test and national screening programs, the disease remains a leading killer of women in low- and middle-income countries for lack of access to screening and trained providers.
Kathleen Schmeler, M.D., professor of Gynecologic Oncology and Reproductive Medicine, is working change this. Her work to prevent and treat cervical cancer has taken...
Despite the fact that the human papillomavirus (HPV) vaccine has been available in the U.S. for over 10 years and remains the only vaccine...
A study from researchers at The University of Texas MD Anderson Cancer Center found that the prevalence of the types of oral human papillomavirus...
MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million grant to evaluate innovative approaches to increase screening and prevention of cervical cancers in Mozambique, which has some of the highest rates of cervical cancer in the world.
The grant was awarded by the Partnerships for Enhanced Engagement in Research (PEER) program, sponsored by the U.S...
In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.
Having spent the...
This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the University...
Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as much as...
As national vaccination rates for the human papillomavirus (HPV) remain low, MD Anderson Cancer Center has again united with the...
According to a recent report from the Centers for Disease Control and Prevention (CDC), adolescent vaccination rates for the human...
The Food and Drug Administration’s (FDA) approval of a new vaccine that targets five additional strains of human papillomavirus (HPV) fortifies...